AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2023
Sep 6, 2023
30786_dirs_2023-09-06_032c2a6d-9397-4309-b7d4-801485618854.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2023-09-01
Reporting Person: ERNST TIMOTHY S (EVP, General Counsel & Sec)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-01 | Bio-Rad A Common Stock | M | 347 | — | Acquired | 2762.7965 | Direct |
| 2023-09-01 | Bio-Rad A Common Stock | F | 173 | $394.60 | Disposed | 2589.7965 | Direct |
| 2023-09-01 | Bio-Rad A Common Stock | M | 253 | — | Acquired | 2842.7965 | Direct |
| 2023-09-01 | Bio-Rad A Common Stock | F | 126 | $394.60 | Disposed | 2716.7965 | Direct |
| 2023-09-02 | Bio-Rad A Common Stock | M | 361 | — | Acquired | 3077.7965 | Direct |
| 2023-09-02 | Bio-Rad A Common Stock | F | 179 | $394.60 | Disposed | 2898.7965 | Direct |
| 2023-09-03 | Bio-Rad A Common Stock | M | 464 | — | Acquired | 3362.7965 | Direct |
| 2023-09-03 | Bio-Rad A Common Stock | F | 231 | $394.60 | Disposed | 3131.7965 | Direct |
| 2023-09-04 | Bio-Rad A Common Stock | M | 500 | — | Acquired | 3631.7965 | Direct |
| 2023-09-04 | Bio-Rad A Common Stock | F | 248 | $394.60 | Disposed | 3383.7965 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-09-01 | Restricted Stock Units | $0 | A | 2003 | Acquired | Bio-Rad A Common Stock (2003) | Direct | |
| 2023-09-01 | Restricted Stock Units | $0 | M | 347 | Disposed | Bio-Rad A Common Stock (347) | Direct | |
| 2023-09-01 | Restricted Stock Units | $0 | M | 253 | Disposed | Bio-Rad A Common Stock (253) | Direct | |
| 2023-09-02 | Restricted Stock Units | $0 | M | 361 | Disposed | Bio-Rad A Common Stock (361) | Direct | |
| 2023-09-03 | Restricted Stock Units | $0 | M | 464 | Disposed | Bio-Rad A Common Stock (464) | Direct | |
| 2023-09-04 | Restricted Stock Units | $0 | M | 500 | Disposed | Bio-Rad A Common Stock (500) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F4: On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F5: On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F7: On September 3, 2019, the reporting person was granted 2,320 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F8: On September 4, 2018, the reporting person was granted 2,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.